The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $35.98

Today's change-0.36 -0.99%
Updated October 16 4:00 PM EDT. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $35.98

Today's change-0.36 -0.99%
Updated October 16 4:00 PM EDT. Delayed by at least 15 minutes.

Pfizer Inc down (U.S.)$0.36

Pfizer Inc closed lower Monday, dropping (U.S.)$0.36 or 0.99% to (U.S.)$35.98. Shares have lost 0.44% over the last five days, but sit 1.69% below their 52-week high. This security has underperformed the S&P 500 by 9.74% during the last year.

Key company metrics

  • Open(U.S.) $36.35
  • Previous close(U.S.) $36.34
  • High(U.S.) $36.48
  • Low(U.S.) $35.88
  • Bid / Ask-- / --
  • YTD % change+10.78%
  • Volume13,581,579
  • Average volume (10-day)13,801,954
  • Average volume (1-month)17,383,764
  • Average volume (3-month)17,638,377
  • 52-week range(U.S.) $29.83 to (U.S.) $36.60
  • Beta1.00
  • Trailing P/E26.21×
  • P/E 1 year forward14.20×
  • Forward PEG2.35×
  • Indicated annual dividend(U.S.) $1.28
  • Dividend yield3.56%
  • Trailing EPS(U.S.) $1.37
Updated October 16 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.03%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 02, 201707/02/2017Apr 02, 201704/02/2017Dec 31, 201612/31/2016Oct 02, 201610/02/2016
Revenue12,89612,77913,62813,045
Total other revenue--------
Total revenue12,89612,77913,62813,045
Gross profit10,24210,30610,4149,963
Total cost of revenue2,6542,4733,2143,082
Total operating expense8,8878,55212,70711,335
Selling / general / administrative3,4253,3084,4233,559
Research & development1,7801,7082,5121,881
Depreciation / amortization1,2081,1861,122968
Interest expense (income), net operating--------
Unusual expense (income)981961,4942,118
Other operating expenses, total-278-319-58-273
Operating income4,0094,2279211,710
Interest income (expense), net non-operating-331-325-312-309
Gain (loss) on sale of assets34959047
Other--------
Income before tax3,8153,9517761,604
Income after tax3,0763,1308471,320
Income tax, total739821-71284
Net income3,0733,1218581,320
Total adjustments to net income----1-1
Net income before extra. items3,0713,1218411,320
Minority interest-5-9-60
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,0713,1218421,319
Inc. avail. to common incl. extra. items3,0733,1218591,319
Diluted net income3,0733,1218591,319
Dilution adjustment--0--0
Diluted weighted average shares6,0376,0926,1446,138
Diluted EPS excluding extraordinary itemsvalue per share0.510.510.140.21
Dividends per sharevalue per share0.320.320.300.30
Diluted normalized EPSvalue per share0.520.520.360.54